Sermorelin

Product Description Sermorelin is a synthetic 29-amino acid peptide analog of growth hormone-releasing hormone (GHRH). It corresponds to the biologically active N-terminal fragment of native human GHRH. Supplied as ≥98% pure lyophilized powder (HPLC/MS verified), it is designed for laboratory studies on growth hormone regulation, pituitary function, metabolism, and tissue repair.

Key Research Mechanism Sermorelin binds to the growth hormone-releasing hormone receptor (GHRHR) in the anterior pituitary, stimulating pulsatile release of endogenous growth hormone (GH). This leads to increased IGF-1 production, promoting protein synthesis, lipolysis, and cellular regeneration while preserving natural feedback mechanisms.

Primary Research Areas

• Growth hormone secretion and pituitary signaling studies
• Muscle growth, recovery, and lean mass maintenance in animal models
• Fat metabolism and body composition research
• Bone density, wound healing, and age-related hormone decline investigations

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.